Date Title Description PDF
15 Mar 2022 On significant placements in financial instruments Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. Download
14 Mar 2022 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. Download
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download

Pages

Date Title Description PDF
21 Feb 2023 Annual Corporate Governance Report ROVI releases the 2022 Annual Corporate Governance Report Download
21 Feb 2023 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors Download
16 Feb 2023 On business and financial situation The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. Download
09 Jan 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the fourth quarter of 2022 Download
15 Dec 2022 On Corporate Governance The Company informs about changes in the Board of Directors and the creation of an Advisory Committee. Download

Pages

Date Title Description PDF
21 Feb 2013 Información sobre resultados (2) Download
21 Feb 2013 Información sobre resultados Download
21 Feb 2013 Informe Anual de Gobierno Corporativo 2012 Download
08 Nov 2012 Información financiera intermedia Download
08 Nov 2012 Información sobre resultados Download

Pages